Several ALS- and FTD-associated mutations in the SQSTM1/p62 gene have been found to impair the interaction of SQSTM1/p62 with KEAP1, in turn decreasing the NRF2 antioxidant transcriptional response [132,134,135,136]. This evidence concerns the gene NFE2L2 and frontotemporal dementia.